Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Intensive Care Medicine|February 8, 2000
Kinetics and characteristics of an acute phase response following cardiac arrestM Oppert, C H Gleiter, C Müller, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 13, 2007
In vitro metabolite identification of ML3403, a 4-pyridinylimidazole-type p38 MAP kinase inhibitor by LC-Qq-TOF-MS and LC-SPE-cryo-NMR/MSB Kammerer, H Scheible, G Zurek, et al.
Deutsche Medizinische Wochenschrift (1946)|November 29, 2002
["Off-label" prescribing of drugs in the ambulatory care of children and adolescents]R Bücheler, C Meisner, B Kalchthaler, et al.
Alimentary Pharmacology & Therapeutics|January 21, 2006
Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's diseaseK Dilger, M Alberer, A Busch, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Role of cytochrome P4502D6 in the metabolism of brofaromine. A new selective MAO-A inhibitorN Feifel, K Kucher, L Fuchs, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 10, 2006
Effect of endothelin-1 on erythropoietin production in a rat model under normoxia and functional carbon monoxide-induced hypoxiaA Grenz, J Klein, C Köhle, et al.
The American Journal of Psychiatry|June 9, 1999
Persistence of haloperidol in human brain tissueJ Kornhuber, A Schultz, J Wiltfang, et al.
Clinical Pharmacology and Therapeutics|December 9, 1997
Dexamethasone down-regulates the expression of L-selectin on the surface of neutrophils and lymphocytes in humansB Jilma, J Voltmann, S Albinni, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 26, 2005
What do primary care patients think about generic drugs?W Himmel, A Simmenroth-Nayda, W Niebling, et al.
Journal of Clinical Pharmacology|November 10, 1998
When are bioavailability studies required? A German proposalC H Gleiter, U Klotz, J Kuhlmann, et al.
Pageof 8